CO-1686(Rociletinib)
-
- Product NameCO-1686(Rociletinib)
- CAS No.1374640-70-6
- Purity98%
- Min Quantity
- Price200~1300
- View Contact Detail
Detailed Description
CO-1686(Rociletinib) is an irreversible inhibitor of epidermal growth factor receptor (EGFR).CO-1686(Rociletinib) was used for EGFR-Mutated NonCSmall-Cell Lung Cancer.Rociletinib was active in patients with EGFR-mutated NSCLC associated with the T790M resistance mutation. (Funded by Clovis Oncology; ClinicalTrials.gov number, NCT01526928.)